[4-[2-(3-chlorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;(1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(2-phenyltetrazole-5-carbonyl)piperazin-1-yl]methanone;bis((1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(1-phenyl-1,2,4-triazole-3-carbonyl)piperazin-1-yl]methanone);[4-[2-(2-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(3-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(4-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone
C167H171ClF3N47O18 — CID 158215998
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[2-(3-chlorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;(1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(2-phenyltetrazole-5-carbonyl)piperazin-1-yl]methanone;bis((1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(1-phenyl-1,2,4-triazole-3-carbonyl)piperazin-1-yl]methanone);[4-[2-(2-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(3-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(4-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone
[4-[2-(3-chlorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;(1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(2-phenyltetrazole-5-carbonyl)piperazin-1-yl]methanone;bis((1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(1-phenyl-1,2,4-triazole-3-carbonyl)piperazin-1-yl]methanone);[4-[2-(2-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(3-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(4-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone (PubChem CID 158215998) has the molecular formula C167H171ClF3N47O18 and a molecular weight of 3216.96 g/mol. Its IUPAC name is [4-[2-(3-chlorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;(1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(2-phenyltetrazole-5-carbonyl)piperazin-1-yl]methanone;bis((1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(1-phenyl-1,2,4-triazole-3-carbonyl)piperazin-1-yl]methanone);[4-[2-(2-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(3-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(4-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone.
Molecular Properties
| Compound Name | [4-[2-(3-chlorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;(1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(2-phenyltetrazole-5-carbonyl)piperazin-1-yl]methanone;bis((1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(1-phenyl-1,2,4-triazole-3-carbonyl)piperazin-1-yl]methanone);[4-[2-(2-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(3-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(4-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone |
|---|---|
| PubChem CID | 158215998 |
| Molecular Formula | C167H171ClF3N47O18 |
| Molecular Weight | 3216.96 g/mol |
| Exact Mass | 3214.36 |
| IUPAC Name | [4-[2-(3-chlorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;(1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(2-phenyltetrazole-5-carbonyl)piperazin-1-yl]methanone;bis((1-cyclopropylisoquinolin-3-yl)-[3,3-dimethyl-4-(1-phenyl-1,2,4-triazole-3-carbonyl)piperazin-1-yl]methanone);[4-[2-(2-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(3-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone;[4-[2-(4-fluorophenyl)tetrazole-5-carbonyl]-3,3-dimethylpiperazin-1-yl]-(6-methoxy-2-pyridinyl)methanone |
| SMILES | CC1(C)CN(C(=O)c2cc3ccccc3c(C3CC3)n2)CCN1C(=O)c1ncn(-c2ccccc2)n1.CC1(C)CN(C(=O)c2cc3ccccc3c(C3CC3)n2)CCN1C(=O)c1ncn(-c2ccccc2)n1.CC1(C)CN(C(=O)c2cc3ccccc3c(C3CC3)n2)CCN1C(=O)c1nnn(-c2ccccc2)n1.COc1cccc(C(=O)N2CCN(C(=O)c3nnn(-c4ccc(F)cc4)n3)C(C)(C)C2)n1.COc1cccc(C(=O)N2CCN(C(=O)c3nnn(-c4cccc(Cl)c4)n3)C(C)(C)C2)n1.COc1cccc(C(=O)N2CCN(C(=O)c3nnn(-c4cccc(F)c4)n3)C(C)(C)C2)n1.COc1cccc(C(=O)N2CCN(C(=O)c3nnn(-c4ccccc4F)n3)C(C)(C)C2)n1 |
| InChI | InChI=1S/2C28H28N6O2.C27H27N7O2.C21H22ClN7O3.3C21H22FN7O3/c2*1-28(2)17-32(26(35)23-16-20-8-6-7-11-22(20)24(30-23)19-12-13-19)14-15-33(28)27(36)25-29-18-34(31-25)21-9-4-3-5-10-21;1-27(2)17-32(25(35)22-16-19-8-6-7-11-21(19)23(28-22)18-12-13-18)14-15-33(27)26(36)24-29-31-34(30-24)20-9-4-3-5-10-20;2*1-21(2)13-27(19(30)16-8-5-9-17(23-16)32-3)10-11-28(21)20(31)18-24-26-29(25-18)15-7-4-6-14(22)12-15;1-21(2)13-27(19(30)15-8-6-10-17(23-15)32-3)11-12-28(21)20(31)18-24-26-29(25-18)16-9-5-4-7-14(16)22;1-21(2)13-27(19(30)16-5-4-6-17(23-16)32-3)11-12-28(21)20(31)18-24-26-29(25-18)15-9-7-14(22)8-10-15/h2*3-11,16,18-19H,12-15,17H2,1-2H3;3-11,16,18H,12-15,17H2,1-2H3;2*4-9,12H,10-11,13H2,1-3H3;2*4-10H,11-13H2,1-3H3 |
| InChIKey | GCQOTHDOYHLNFT-UHFFFAOYSA-N |
| XLogP | 18.45 |
| TPSA | 690.91 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 51 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 236 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3216.96 |
| LogP ≤ 5 | 18.45 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 51 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158215998 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.